SEC Form 4 · accession 0001209191-16-133419
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry D Quart
Officer — Chief Executive Officer · Director
Period of report
Jul 19, 2016
Accepted (ET)
Jul 20, 2016 · 8:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 29, 2016 | J | 837 | $18.224 | A | 61,679 | D | |
| Common Stock | Jul 19, 2016 | M | 4,630 | $7.20 | A | 66,309 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $7.20 | Jul 19, 2016 | M | 4,630 | D | — | May 1, 2023 | Common Stock | 4,630 | 930,277 | D |
Explanation of responses
- F1Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 29, 2016.
- F2Cash exercise and hold.
- F3At the date of filing, 255,220 shares of the options granted pursuant to the underlying awards are fully vested and exercisable.